These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24006591)

  • 1. [Laboratory screening of short stature children].
    Füessl HS
    MMW Fortschr Med; 2013 Aug; 155(14):33. PubMed ID: 24006591
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for colorectal cancer: which test can we afford?
    Lansdorp-Vogelaar I; van Ballegooijen M; Kuipers EJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S38-40. PubMed ID: 18368641
    [No Abstract]   [Full Text] [Related]  

  • 3. [2009 laboratory reform--what needs consideration].
    Zimmermann GW
    MMW Fortschr Med; 2008 Sep; 150(36-37):8-9. PubMed ID: 18986112
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dr. Wolfgang Holz, NAV, on laboratory reform. KBV has set costs much too low. Interview by Wolfgang Loosen].
    Holz W
    MMW Fortschr Med; 1999 Sep; 141(35):52-3. PubMed ID: 10897961
    [No Abstract]   [Full Text] [Related]  

  • 5. [The costs of depression and the cost-effectiveness of treatment].
    König HH; Luppa M; Riedel-Heller S
    Psychiatr Prax; 2010 Jul; 37(5):213-5. PubMed ID: 20597034
    [No Abstract]   [Full Text] [Related]  

  • 6. [Do you reflect before every treatment: what is this patient worth to society?].
    Wiedemann B
    MMW Fortschr Med; 2002 Dec; 144(50):58. PubMed ID: 14610869
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mammography screening in Germany: how, when and why?].
    Bick U
    Rofo; 2006 Oct; 178(10):957-69. PubMed ID: 17021975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development and first results of fast and cost-effective examination methods for an ophthalmological screening within the National Cohort].
    Leitritz MA; Hense HW; Schiefer U; Nagel M; Greiser H; Linseisen J; Heid I; Fischer B; Thierry S; Bartz-Schmidt KU; Ueffing M
    Klin Monbl Augenheilkd; 2013 Dec; 230(12):1238-46. PubMed ID: 24104960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Palliative care with respect to demographic change. How much can society afford?].
    Schmacke N
    Med Klin (Munich); 2007 Jul; 102(7):582-5. PubMed ID: 17634877
    [No Abstract]   [Full Text] [Related]  

  • 10. [Screening for colorectal cancer: a cost benefit analysis on a health prevention programme at the Boehringer Ingelheim Company].
    Schneider M; Häck HJ
    Dtsch Med Wochenschr; 2011 May; 136(20):1047-52. PubMed ID: 21560104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A short-term diagnostic and economic impact model of neonatal screening for cystic fibrosis].
    Rasch A; Perleth M
    Klin Padiatr; 2011 Mar; 223(2):96-103. PubMed ID: 21305445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland.
    Gillespie P; O'Neill C; Adams E; Turner K; O'Donovan D; Brugha R; Vaughan D; O'Connell E; Cormican M; Balfe M; Coleman C; Fitzgerald M; Fleming C
    Sex Transm Infect; 2012 Apr; 88(3):222-8. PubMed ID: 22213681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of the COPD health care costs study. COPD in Germany--unrecognized and cost intensive].
    Krankenpfl J; 2003; 41(7-9):158-61. PubMed ID: 14705523
    [No Abstract]   [Full Text] [Related]  

  • 14. [Screening at the general pratitioner].
    Füessl HS
    MMW Fortschr Med; 2010 Oct; 152(40):34. PubMed ID: 21049639
    [No Abstract]   [Full Text] [Related]  

  • 15. [Maximal diagnosis in a restless child].
    Hakimi R
    Versicherungsmedizin; 2004 Mar; 56(1):41. PubMed ID: 15049474
    [No Abstract]   [Full Text] [Related]  

  • 16. [Which M-III or M-IV service can I claim with IGeL?].
    Walbert H
    MMW Fortschr Med; 2013 May; 155(10):10. PubMed ID: 23930399
    [No Abstract]   [Full Text] [Related]  

  • 17. [On call service. May I not claim C-reactive protein test fee?].
    Walbert H
    MMW Fortschr Med; 2015 Jan; 157(1):14. PubMed ID: 25767862
    [No Abstract]   [Full Text] [Related]  

  • 18. [Legislation by BMGS on evaluation of cost effectiveness].
    GFB
    Chirurg; 2004 Mar; 75(3):M76. PubMed ID: 15080093
    [No Abstract]   [Full Text] [Related]  

  • 19. [Routine health screening, yes or no? It depends].
    Köck CM
    Wien Klin Wochenschr; 1997 Mar; 109(5):141-4. PubMed ID: 9173661
    [No Abstract]   [Full Text] [Related]  

  • 20. [The development of a model to calculate the cost of care for the severely injured--an initiative of the Trauma Register of the DGU].
    Pape HC; Grotz M; Schwermann T; Ruchholtz S; Lefering R; Rieger M; Tröger M; Graf von der Schulenburg JM; Krettek C;
    Unfallchirurg; 2003 Apr; 106(4):348-57. PubMed ID: 12719857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.